iiinova — where your digital self keeps evolving

shrutipatelmd.bsky.social @shrutipatelmd.bsky.social · 29/04/2025

1/ 🚨 First-in-human study of CRISPR-Cas9-edited TILs targeting the intracellular checkpoint CISH in metastatic CRC, led by my friend Dr. Emil Lou @cancerassassin1.bsky.social, presented at #AACR24 thelancet.com/journals/lan... #oncology #crc Key findings from this landmark phase 1 trial 🧵:

thelancet.com

Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial

These results support the safety and potential antitumour activity of inhibiting the immune checkpoint CISH through the administration of neoantigen-reactive CISH-knockout TILs, with implications for ...

132